Spots Global Cancer Trial Database for tilsotolimod with ipilimumab
Every month we try and update this database with for tilsotolimod with ipilimumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma | NCT03445533 | Metastatic Mela... | Ipilimumab Tilsotolimod wi... | 18 Years - | Idera Pharmaceuticals, Inc. |